VaramirStart free · no cardSign in
ETON as of Oct 31 · 22:56 ET
ETONNasdaqPharmaceutical Preparations

Eton Pharmaceuticals, Inc. · Brief

Next report

4 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±12.9%
avg realized
±12.1%
Nov 12 '24±14.2%▲+15.59%×1.10
Mar 18 '25±11.7%▼−3.99%×0.34
May 13 '25±14.0%▲+0.29%×0.02
Aug 7 '25±17.1%▲+12.32%×0.72
Q3 FY25±18.1%▼−11.70%×0.64
Q1 FY26±10.6%▲+7.46%×0.70
May 14 '26±6.6%▲+1.00%×0.15
Q2 FY26±10.6%▲+44.26%×4.19
quarterimplied−45%0+45%realized×
Q2 FY26±10.6%▲+44.26%×4.19
May '26±6.6%▲+1.00%×0.15
Q1 FY26±10.6%▲+7.46%×0.70
Q3 FY25±18.1%▼−11.70%×0.64
Aug '25±17.1%▲+12.32%×0.72
May '25±14.0%▲+0.29%×0.02
2 older reports
Mar '25±11.7%▼−3.99%×0.34
Nov '24±14.2%▲+15.59%×1.10
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

164managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+6.64%change in shares held by the ten largest reporting managers13F · Jun 30 '26

Bear2 of 4

84.60%share of revenue from the largest disclosed customer AnovoRxSEC filings
0.03%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ETON report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±16.4% into Nov 5 earnings (Oct 22 close).Source
Oct 148-KMaterial agreement: License Agreement and Supply Agreement with Aquestive Therapeutics, Inc.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.